EP3166939
THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.7.2015EP published:
5.6.2019EP application number:
15744417.5
EPO information:
European Patent Register
Max expiry date:
6.7.2035
Title:
THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
Timeline
Today
7.7.2015EP application
5.6.2019EP Publication
Owner
Name:
Genentech, Inc.Address:
1 DNA Way, 94080-4990, South San Francisco, CA, US
Name:
Xenon Pharmaceuticals Inc.Address:
200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, CA
Inventor
Name:
ANDREZ, Jean-ChristopheAddress:
BurnabyBritish Columbia V5G 4W8, CA
Name:
BERGERON, PhilippeAddress:
South San Francisco, CA, US
Name:
BICHLER, Paul RobertAddress:
BurnabyBritish Columbia V5G 4W8, CA
Name:
CHOWDHURY, SultanAddress:
BurnabyBritish Columbia V5G 4W8, CA
Name:
DEHNHARDT, Christoph MartinAddress:
BurnabyBritish Columbia V5G 4W8, CA
Name:
FOCKEN, ThiloAddress:
BurnabyBritish Columbia V5G 4W8, CA
Name:
GONG, WeiAddress:
BurnabyBritish Columbia V5G 4W8, CA
Name:
GRIMWOOD, Michael EdwardAddress:
BurnabyBritish Columbia V5G 4W8, CA
Name:
HASAN, AbidAddress:
BurnabyBritish Columbia V5G 4W8, CA
Name:
HEMEON, Ivan WilliamAddress:
BurnabyBritish Columbia V5G 4W8, CA
Name:
JIA, QiAddress:
BurnabyBritish Columbia V5G 4W8, CA
Name:
SAFINA, BrianAddress:
South San Francisco, CA, US
Name:
SUN, ShaoyiAddress:
BurnabyBritish Columbia V5G 4W8, CA
Name:
WILSON, Michael ScottAddress:
BurnabyBritish Columbia V5G 4W8, CA
Name:
ZENOVA, Alla YurevnaAddress:
BurnabyBritish Columbia V5G 4W8, CA
Priority
Number:
201462021587 PDate:
7.7.2014Country:
US
Classification
Categories:
C07D 403/12, C07D 413/14, C07D 221/22, C07D 401/10, C07D 401/12, C07D 403/10, C07D 413/12, C07C 235/52, C07D 205/04, C07D 207/16, C07D 277/06, C07D 209/02, C07D 305/08, A61K 31/401, A61P 17/04